MCAM and metastatic neoplasm: Bidard et al. detected UM CTCs in only 30% of patients with metastatic disease using the CellSearch (Menarini Silicon Biosystems, Florence, Italy) system which targets the melanoma marker MCAM (melanoma cell adhesion molecule) and stains for MCSP [14].